Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 8, 2008 - Issue 9
Submit an article Journal homepage
137
Views
16
CrossRef citations to date
0
Altmetric
Review

Migraine genetics

Pasquale Montagna Department of Neurological Sciences, University of Bologna Medical School, Via U. Foscolo 7, 40123 Bologna, Italy. [email protected]
Pages 1321-1330 | Published online: 09 Jan 2014

References

  • Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia24, 1–160 (2004).
  • Russell MB, Iselius L, Olesen J. Migraine without aura and migraine with aura are inherited disorders. Cephalalgia16, 305–309 (1996).
  • Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB. Evidence for a genetic factor in migraine with aura: a population-based Danish twin study. Ann. Neurol.45, 242–246 (1999).
  • Russell MB, Ulrich V, Gervil M, Olesen J. Migraine without aura and migraine with aura are distinct disorders. A population-based twin survey. Headache42, 332–336 (2002).
  • Bigal ME, Lipton RB, Winner P et al. Migraine in adolescents: association with socioeconomic status and family history. Neurology69, 16–25 (2007).
  • Ulrich V, Olesen J, Gervil M, Russell MB. Possible risk factors and precipitants for migraine with aura in discordant twin-pairs: a population-based study. Cephalalgia20, 821–825 (2000).
  • Devoto M, Lozito A, Staffa G, D’Alessandro R, Sacquegna T, Romeo G. Segregation analysis of migraine in 128 families. Cephalalgia6, 101–105 (1986).
  • Mochi M, Sangiorgi S, Cortelli P et al. Testing models for genetic determination in migraine. Cephalalgia13, 389–394 (1993).
  • Russell MB, Iselius L, Olesen J. Inheritance of migraine investigated by complex segregation analysis. Hum. Genet.96, 726–730 (1995).
  • Merikangas KR, Merikangas JR, Angst J. Headache syndromes and psychiatric disorders: association and familial transmission. J. Psychiatr. Res.27, 197–210 (1993).
  • Chen TC, Leviton A. Asthma and eczema in children born to women with migraine. Arch. Neurol.47, 1227–1230 (1990).
  • Gurkan F, Ece A, Haspolat K, Dikici B. Parental history of migraine and bronchial asthma in children. Allergol. Immunopathol. (Madr.)28, 15–17 (2000).
  • Mortimer MJ, Kay J, Gawkrodger DJ, Jaron A, Barker DC. The prevalence of headache and migraine in atopic children: an epidemiological study in general practice. Headache33, 427–431 (1993).
  • Wessman M, Kallela M, Kaunisto MA et al. A susceptibility locus for migraine with aura, on chromosome 4q24. Am. J. Hum. Genet.70, 652–662 (2002).
  • Cader ZM, Noble-Topham S, Dyment DA et al. Significant linkage to migraine with aura on chromosome 11q24. Hum. Mol. Genet.12, 2511–2517 (2003).
  • Russo L, Mariotti P, Sangiorgi E et al. A new susceptibility locus for migraine with aura in the 15q11-q13 genomic region containing three GABA-A receptor genes. Am. J. Hum. Genet.76, 327–333 (2005).
  • Soragna D, Vettori A, Carraro G et al. A locus for migraine without aura maps on chromosome 14q21.2-q22.3. Am. J. Hum. Genet.72, 161–167 (2003).
  • Carlsson A, Forsgren L, Nylander PO et al. Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1. Neurology59, 1804–1807 (2002).
  • Nyholt DR, Dawkins JL, Brimage PJ, Goadsby PJ, Nicholson GA, Griffiths LR. Evidence for an X-linked genetic component in familial typical migraine. Hum. Mol. Genet.7, 459–463 (1998).
  • Nyholt DR, Curtain RP, Griffiths LR. Familial typical migraine: significant linkage and localization of a gene to Xq24–28. Hum. Genet.107, 18–23 (2000).
  • Bjornsson A, Gudmundsson G, Gudfinnsson E et al. Localization of a gene for migraine without aura to chromosome 4q21. Am. J. Hum. Genet.73, 986–993 (2003).
  • McCarthy LC, Hosford DA, Riley JH et al. Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics78, 135–149 (2001).
  • Curtain R, Tajouri L, Lea R, Macmillan J, Griffiths L. No mutations detected in the INSR gene in a chromosome 19p13 linked migraine pedigree. Eur. J. Med. Genet.49, 57–62 (2006).
  • Mochi M, Cevoli S, Cortelli P et al. Investigation of an LDLR gene polymorphism (19p13.2) in susceptibility to migraine without aura. J. Neurol. Sci.213, 7–10 (2003).
  • Curtain R, Lea RA, Quinlan S et al. Investigation of the low-density lipoprotein receptor gene and cholesterol as a risk factor for migraine. J. Neurol. Sci.227, 95–100 (2004).
  • Montagna P. The primary headaches: genetics, epigenetics and a behavioural genetic model. J. Headache Pain9, 57–69 (2008)
  • Joutel A, Bousser MG, Biousse V et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat. Genet.5, 40–45 (1993).
  • Ophoff RA, Terwindt GM, Vergouwe MN et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell87, 543–552 (1996).
  • Plomp JJ, Vergouwe MN, Van den Maagdenberg AM, Ferrari MD, Frants RR, Molenaar PC. Abnormal transmitter release at neuromuscular junctions of mice carrying the tottering α1A Ca2+ channel mutation. Brain123, 463–471 (2000).
  • Zhuchenko O, Bailey J, Bonnen P et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat. Genet.15, 62–69 (1997).
  • Gardner K, Barmada MM, Ptacek LJ, Hoffman EP. A new locus for hemiplegic migraine maps to chromosome 1q31. Neurology49, 1231–1238 (1997).
  • Ducros A, Joutel A, Vahedi K et al. Mapping of a second locus for familial hemiplegic migraine to 1q21–q23 and evidence of further heterogeneity. Ann. Neurol.42, 885–890 (1997).
  • De Fusco M, Marconi R, Silvestri L et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet.33, 192–196 (2003).
  • Dichgans M, Freilinger T, Eckstein G et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet366, 371–377 (2005).
  • Terwindt GM, Ophoff RA, Haan J, Sandkuijl LA, Frants RR, Ferrari MD. Migraine, ataxia and epilepsy: a challenging spectrum of genetically determined calcium channelopathies. Dutch Migraine Genetics Research Group. Eur. J. Hum. Genet.6, 297–307 (1998).
  • Pietrobon D, Striessnig J. Neurobiology of migraine. Nat. Rev. Neurosci.4, 386–398 (2003).
  • van den Maagdenberg AM, Pietrobon D, Pizzorusso T et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron41, 701–710 (2004).
  • May A, Ophoff RA, Terwindt GM et al. Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura. Hum. Genet.96, 604–608 (1995).
  • Terwindt GM, Ophoff RA, van Eijk R et al. Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology56, 1028–1032 (2001).
  • Todt U, Dichgans M, Jurkat-Rott K et al. Rare missense variants in ATP1A2 in families with clustering of common forms of migraine. Hum. Mutat.26, 315–321 (2005).
  • Hovatta I, Kallela M, Färkkilä M, Peltonen L. Familial migraine: exclusion of the susceptibility gene from the reported locus of familial hemiplegic migraine on 19p. Genomics23, 707–709 (1994).
  • Monari L, Mochi M, Valentino ML et al. Searching for migraine genes: exclusion of 290 cM out of the whole human genome. Ital. J. Neurol. Sci.18, 277–282 (1997).
  • Kim JS, Yue Q, Jen JC, Nelson SF, Baloh RW. Familial migraine with vertigo: no mutations found in CACNA1A. Am. J. Med. Genet.79, 148–151 (1998).
  • Noble-Topham SE, Dyment DA, Cader MZ et al. Migraine with aura is not linked to the FHM gene CACNA1A or the chromosomal region, 19p13. Neurology59, 1099–1101 (2002).
  • Jones KW, Ehm MG, Pericak-Vance MA, Haines JL, Boyd PR, Peroutka SJ. Migraine with aura susceptibility locus on chromosome 19p13 is distinct from the familial hemiplegic migraine locus. Genomics78, 150–154 (2001).
  • Brugnoni R, Leone M, Rigamonti A et al. Is the CACNA1A gene involved in familial migraine with aura? Neurol. Sci.23, 1–5 (2002).
  • Wieser T, Mueller C, Evers S, Zierz S, Deufel T. Absence of known familial hemiplegic migraine (FHM) mutations in the CACNA1A gene in patients with common migraine: implications for genetic testing. Clin. Chem. Lab. Med.41, 272–275 (2003).
  • Jen JC, Kim GW, Dudding KA, Baloh RW. No mutations in CACNA1A and ATP1A2 in probands with common types of migraine. Arch. Neurol.61, 926–928 (2004).
  • Curtain RP, Lea RA, Tajouri L et al. Analysis of chromosome 1 microsatellite markers and the FHM2-ATP1A2 gene mutations in migraine pedigrees. Neurol. Res.27, 647–652 (2005).
  • von Brevern M, Ta N, Shankar A et al. Migrainous vertigo: mutation analysis of the candidate genes CACNA1A, ATP1A2, SCN1A, and CACNB4. Headache46, 1136–1141 (2006).
  • Netzer C, Todt U, Heinze A et al. Haplotype-based systematic association studies of ATP1A2 in migraine with aura. Am. J. Med. Genet. B Neuropsychiatr. Genet.141, 257–260 (2006).
  • Kirchmann M, Thomsen LL, Olesen J. The CACNA1A and ATP1A2 genes are not involved in dominantly inherited migraine with aura. Am. J. Med. Genet. B Neuropsychiatr. Genet.141, 250–256 (2006).
  • Thomsen LL, Kirchmann M, Bjornsson A et al. The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain130, 346–356 (2007).
  • Terwindt G, Kors E, Haan J et al. Mutation analysis of the CACNA1A calcium channel subunit gene in 27 patients with sporadic hemiplegic migraine. Arch. Neurol.59, 1016–1018 (2002).
  • Thomsen L, Oestergaard E, Bjornsson A et al. Screen for CACNA1A and ATP1A2 mutations in sporadic hemiplegic migraine patients. Cephalalgia (2008) (Epub ahead of print).
  • de Vries B, Freilinger T, Vanmolkot KR et al. Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine. Neurology69, 2170–2176 (2007).
  • Jouvenceau A, Eunson LH, Spauschus A et al. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet358, 801–807 (2001).
  • Vanmolkot KR, Kors EE, Hottenga JJ et al. Novel mutations in the Na+,K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann. Neurol.54, 360–366 (2003).
  • Kors EE, Melberg A, Vanmolkot KR et al. Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia, and a new CACNA1A mutation. Neurology63, 1136–1137 (2004).
  • Beauvais K, Cave-Riant F, De Barace C, Tardieu M, Tournier-Lasserve E, Furby A. New CACNA1A gene mutation in a case of familial hemiplegic migraine with status epilepticus. Eur. Neurol.52, 58–61 (2004).
  • Ducros A, Denier C, Joutel A et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N. Engl. J. Med.345, 17–24 (2001).
  • Cevoli S, Pierangeli G, Monari L et al. Familial hemiplegic migraine: clinical features and probable linkage to chromosome 1 in an Italian family. Neurol. Sci.23, 7–10 (2002).
  • Spadaro M, Ursu S, Lehmann-Horn F et al. A G301R Na+/K+ ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs. Neurogenetics5, 177–185 (2004).
  • Kors EE, Terwindt GM, Vermeulen FL et al. Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann. Neurol.49, 753–760 (2001).
  • Echenne B, Ducros A, Rivier F et al. Recurrent episodes of coma: an unusual phenotype of familial hemiplegic migraine with linkage to chromosome 1. Neuropediatrics30, 214–217 (1999).
  • Spranger M, Spranger S, Schwab S, Benninger C, Dichgans M. Familial hemiplegic migraine with cerebellar ataxia and paroxysmal psychosis. Eur. Neurol.41, 150–152 (1999).
  • Giffin NJ, Benton S, Goadsby PJ. Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation. Dev. Med. Child Neurol.44, 490–493 (2002).
  • Swoboda KJ, Kanavakis E, Xaidara A et al. Alternating hemiplegia of childhood or familial hemiplegic migraine? A novel ATP1A2 mutation. Ann. Neurol.55, 884–887 (2004).
  • Jurkat-Rott K, Freilinger T, Dreier JP et al. Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants. Neurology62, 1857–1861 (2004).
  • Vanmolkot KR, Stroink H, Koenderink JB et al. Severe episodic neurological deficits and permanent mental retardation in a child with a novel FHM2 ATP1A2 mutation. Ann. Neurol.59, 310–314 (2006).
  • Bassi MT, Bresolin N, Tonelli A et al. A novel mutation in the ATP1A2 gene causes alternating hemiplegia of childhood. J. Med. Genet.41, 621–628 (2004).
  • Auvin S, Joriot-Chekaf S, Cuvellier JC, Vallée L. Familial alternating hemiplegia of childhood or channelopathy? A report with valuable pathophysiological implications. Dev. Med. Child Neurol.46, 500 (2004).
  • Kaja S, van de Ven RC, Broos LA et al. Gene dosage-dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness. Neuroscience135, 81–95 (2005).
  • Kaja S, van de Ven RC, van Dijk JG et al. Severely impaired neuromuscular synaptic transmission causes muscle weakness in the Cacna1a-mutant mouse rolling Nagoya. Eur. J. Neurosci.25, 2009–2020 (2007).
  • Montagna P, Gallassi R, Medori R et al. MELAS syndrome: characteristic migrainous and epileptic features and maternal transmission. Neurology38, 751–754 (1988).
  • Goto Y, Horai S, Matsuoka T et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology42, 545–550 (1992).
  • Chabriat H, Vahedi K, Iba-Zizen MT et al. Clinical spectrum of CADASIL: a study of 7 families. Lancet346, 934–939 (1995).
  • Dichgans M, Mayer M, Uttner I. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann. Neurol.44, 731–739 (1998).
  • Ophoff RA, DeYoung J, Service SK et al. Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3. Am. J. Hum. Genet.69, 447–453 (2001).
  • Michael JC, Levin PM. Multiple telangiectases of brain: a discussion of hereditary factors in their development. Arch. Neurol. Psychiat.36, 514–536 (1936).
  • Marini V, Ferrera L, Dorcaratto A. Identification of a novel KRIT1 mutation in an Italian family with cerebral cavernous malformation by the protein truncation test. J. Neurol. Sci.212, 75–78 (2003).
  • Bonifati V, Oostra BA, Heutink P. Unraveling the pathogenesis of Parkinson’s disease – the contribution of monogenic forms. Cell. Mol. Life Sci.61, 1729–1750 (2004).
  • Stefansson H, Rye DB, Hicks A et al. A genetic risk factor for periodic limb movements in sleep. N. Engl. J. Med.357, 639–647 (2007).
  • Winkelmann J, Schormair B, Lichtner P et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat. Genet.39, 1000–1006 (2007).
  • Isles AR and Wilkinson LS. Epigenetics: what is it and why is it important to mental disease? Br. Med. Bull.85, 35–45 (2008).
  • Luedi PP, Dietrich FS, Weidman JR, Bosko JM, Jirtle LR, Hartemink AJ. Computational and experimental identification of novel human imprinted genes. Genome Res.17, 1723–1730 (2007).
  • Oommen AM, Griffin JB, Sarath G, Zempleni J. Roles for nutrients in epigenetic events. J. Nutr. Biochem.16, 74–77 (2005).
  • Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat. Rev. Genet.8, 253–262 (2007).
  • Fraga MF, Ballestar E, Paz MF et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. USA102, 10604–10609 (2005).
  • Francis DD, Szegda K, Campbell G, Martin WD, Insel TR. Epigenetic sources of behavioral differences in mice. Nat. Neurosci.6, 445–446 (2003).
  • Weaver IC, Cervoni N, Champagne FA et al. Epigenetic programming by maternal behaviour. Nat. Neurosci.7, 847–854 (2004).
  • Champagne FA, Weaver IC, Diorio J, Dymov S, Szyf M, Meaney MJ. Maternal care associated with methylation of the estrogen receptor alpha1b promoter and estrogen receptor alpha expression in the medial preoptic area of female offsprings. Endocrinology147, 2909–2915 (2006).
  • Gianfrancesco F, Esposito T. The molecular genetics of migraine: toward the identification of responsible genes. Curr. Genomics7, 1–10 (2006).
  • Weaver IC, Champagne FA, Brown SE et al. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J. Neurosci.25, 11045–11054 (2005).
  • Laird PW. Cancer epigenetics. Hum. Mol. Genet.14, R65–R76 (2005).
  • Dong E, Agis-Balboa RC, Simonini MV, Grayson DR, Costa E, Guidotti A. Reelin and glutamic acid decarboxylase promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc. Natl Acad. Sci. USA102, 12578–12583 (2005).
  • Schurks M. Epigenetics in primary headaches: a new avenue for research. J. Headache Pain9, 191–192 (2008).
  • Montagna P. Epigenetics and pharmaco-epigenetics in the primary headaches. J. Headache Pain9, 193–194 (2008).
  • Montagna P, Cortelli P. Migraine and the autonomic nervous system. In: Clinical Autonomic Disorders: Evaluation and Management. Low PA (Ed.), Lippincott, Williams and Wilkins (2008) (In Press).
  • Wilson SG, Bryant CD, Lariviere WR et al. The heritability of antinociception II: pharmacogenetic mediation of three over-the-counter analgesics in mice. J. Pharmacol. Exp. Ther.305, 755–764 (2003).
  • Chesler EJ, Ritchie J, Kokayell A, Lariviere WR, Wilson SG, Mogil JS. Genotype-dependence of gabapentin and pregabalin sensitivity: the pharmacogenetic mediation of analgesia is specific to the type of pain being inhibited. Pain106, 325–335 (2003).
  • Terner JM, Lomas LM, Smith ES, Barrett AC, Picker MJ. Pharmacogenetic analysis of sex differences in opioid antinociception in rats. Pain106, 381–391 (2003).
  • Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA286(18), 2270–2279 (2001).
  • Maassen VanDenBrink A, Vergouwe MN, Ophoff RA et al. Chromosomal localization of the 5-HT1F receptor gene: no evidence for involvement in response to sumatriptan in migraine patients. Am. J. Med. Genet.77, 415–420 (1998).
  • MaassenVanDenBrink A, Vergouwe MN, Ophoff RA, Saxena PR, Ferrari MD, Frants RR. 5-HT1B receptor polymorphism and clinical response to sumatriptan. Headache38, 288–291 (1998).
  • Schurks M, Kurth T, Stude P et al. G protein β3 polymorphism and triptan response in cluster headache. Clin. Pharmacol. Ther.82, 396–401 (2007).
  • Montagna P, Pierangeli G, Cevoli S, Mochi M, Cortelli P. Pharmacogenetics of headache treatment. Neurol. Sci.26, S143–S147 (2005).
  • Tegeder I, Costigan M, Griffin RS et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat. Med.12, 1269–1277 (2006).
  • Fertleman CR, Baker MD, Parker KA et al. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron52, 767–774 (2006).
  • Cox JJ, Reimann F, Nicholas AK et al. An SCN9A channellopathy causes congenital inability to experience pain. Nature444, 894–898 (2006).
  • Catterall WA, Yu FH. Painful channels. Neuron52, 743–744 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.